학술논문
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure
Document Type
Article
Author
Source
In Reumatología clínica (English Edition) September-October 2020 16(5) Part 1:345-352
Subject
Language
ISSN
2173-5743